Moti Ramgopal, MD, FACP, FIDSA

The benefits of addressing barriers and increasing access to HIV PrEP therapies to high-risk populations across the globe.

An overview of HIV PrEP therapies in the pipeline and their potential roles as they are introduced into the community for use among high-risk populations.

Strategies that can help address disparities in care for patients with HIV and reach high-risk groups of patients to ensure access to screening and PrEP.

The advantages of coordinated care between multiple health care providers when managing patients on HIV PrEP therapy.

Discussion regarding HIV PrEP walkaway rates and strategies that can help support patients and increase adherence to therapy.

Recommendations when talking with patients about goals of HIV PrEP and ensuring a patient-centered approach to care.

The financial burden associated with HIV and the potential effects of PrEP uptake on overall costs of care.

Considerations to help identify and increase utilization of PrEP therapy among patients who are eligible for treatment.

Clinician Moti Ramgopal, MD, FACP, FIDSA, highlights key components of a successful HIV PrEP program and comments on the role of providers in introducing these components throughout a patient’s continuum of care to maximize outcomes.